from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2X5SpRX on June 28, 2019 at 03:03PM
DPharm this week announced it had tapped former Food and Drug Administration commissioner Scott Gottlieb to deliver the keynote address for its upcoming meeting set to kick off Sept. 17 in Boston, Massachusetts.
According to an email, Gottlieb’s during his address will outline his views regarding the modernization of clinical trials.
Featured speakers tapped for the event include:
- Mark Travers, Merck & Co.;
- David Lidsky, Fast Company; and
- Robert Mercer, Starbucks.
For additional information and registration details, click here.
You must be logged in to post a comment.